6th Joint Call of JPIAMR

Basic Information

Control of AMR needs actions addressing issues at human, animal and environmental levels, according to an approach usually referred to as “One Health”. Following publication of the WHO Global priority list of antibiotic-resistant bacteria (including Mycobacterium tuberculosis multi-and extensively drug resistant)[1], the JPIAMR is launching a joint transnational call with the aim to discover new targets, compounds and tools with the potential to help controlling diseases caused by resistant bacteria from the above-mentioned WHO pathogen list in human, animal or environmental settings.

Network JPI AMR
Website https://www.jpiamr.eu/6thcall/
Aim of the joint call Control of AMR needs actions addressing issues at human, animal and environmental levels, according to an approach usually referred to as “One Health”. Following publication of the WHO Global priority list of antibiotic-resistant bacteria (including Mycobacterium tuberculosis multi-and extensively drug resistant)[1], the JPIAMR is launching a joint transnational call with the aim to discover new targets, compounds and tools with the potential to help controlling diseases caused by resistant bacteria from the above-mentioned WHO pathogen list in human, animal or environmental settings.
Type of joint call Two Stages - Call with pre-proposals and full proposals submissions
Events
Launch date 03/01/2018
Deadline Pre-Proposal 07/03/2018 Submitted proposal: n/a
Deadline Full-Proposal 14/06/2018 Submitted proposal: n/a
Evaluation End Date 01/11/2018 Successful proposal: n/a Proposals funded: 10
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups n/a
Participating networks n/a

Organisations Participating

Country Organisation
Belgium National Fund for Scientific Research (FNRS)
Belgium Research Foundation Flanders (FWO)
Czech Republic Ministry of Education Youth and Sports (MEYS-MSMT)
Egypt Academy of Scientific Research and Technology (ASRT)
Finland Academy of Finland (AKA)
France National Research Agency (ANR)
Germany Federal Ministry of Education and Research (BMBF)
Ireland Health Research Board (HRB)
Israel Medical Research Administration Chief Scientist Office Israeli Ministriy of Health (CSO-MOH)
Italy Ministry of Health (MOH/MDS)
Latvia State Education Development Agency (VIAA)
Norway Research Council of Norway (RCN)
Poland National Science Centre (NCN)
Romania Ministry of Education, Research and Innovation (MERI)
Spain Institute of Health Carlos III (ISCIII)
Spain Ministry of Economy and Competitiveness (MINECO)
Sweden Swedish Research Council (VR/SRC)
Switzerland Swiss National Science Foundation (SNSF/SNF)

Funded Projects

Acronym Title Start End No. partners
ANTIBIO-LAB Anti-biofilm therapies using local application of bacterioph... 01/01/2019 31/12/2021 6
Anti-Persistence Fighting antibiotic-resistant superbugs with anti-persister ... 01/01/2019 31/12/2021 4
CRISPRattacK Advancing CRISPR antimicrobials to combat the bacterial path... 01/01/2019 31/12/2021 5
DISRUPT Fighting antimicrobial resistant infections by high-throughp... 01/01/2019 31/12/2021 4
Explore Exploration of the TPP riboswitch as a new target for antibi... 01/01/2019 31/12/2021 5
FLAV4AMR Flavodoxin inhibitors to kill resistant bacteria 01/01/2019 31/12/2021 4
MTI4MDR-TB Development of novel Mycobacterial Tolerance Inhibitors (MTI... 01/01/2019 31/12/2021 5
RESET-ME Restoring E. coli Sensitivity for Antibiotics by blocking To... 01/01/2019 31/12/2021 5
RIBOTARGET Development of novel ribosome-targeting antibiotics 01/01/2019 31/12/2021 7
SCAN Design, synthesis and lead generation of novel siderophore c... 01/01/2019 31/12/2021 3